Company Filing History:
Years Active: 2013
Title: Laurent Debethune: Innovator in Pharmaceutical Chemistry
Introduction
Laurent Debethune is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. His work is characterized by a focus on innovative solutions to complex medical challenges.
Latest Patents
Debethune holds a patent for the sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid, which serves as a DHODH inhibitor. This patent encompasses the sodium salt, pharmaceutically acceptable solvates, pharmaceutical combinations, and methods of treatment. His innovative approach aims to enhance the efficacy of treatments in the pharmaceutical industry.
Career Highlights
Laurent Debethune is currently associated with Almirall, S.A., a prominent pharmaceutical company. His role involves research and development, where he applies his expertise to create effective therapeutic solutions. With a focus on advancing medical science, Debethune has established himself as a key figure in his field.
Collaborations
Some of his notable coworkers include Nuria Garcia Gonzalez and Francesc Carrera Carrera. Their collaborative efforts contribute to the innovative environment at Almirall, fostering advancements in pharmaceutical research.
Conclusion
Laurent Debethune's work exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions, particularly in the development of new therapeutic agents, highlight the importance of research and collaboration in advancing healthcare solutions.